Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1992-12-02
1994-10-25
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514104, 514960, 514961, A61K 3166
Patent
active
053589416
ABSTRACT:
Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
REFERENCES:
patent: 4942157 (1990-07-01), Gall et al.
patent: 5041428 (1991-08-01), Isomura et al.
patent: 5047246 (1991-09-01), Gallian et al.
patent: 5070108 (1991-12-01), Margolis
patent: 5158944 (1992-10-01), Makino et al.
Remington's Pharmaceuticals Science, 15th Edition Mack Pub. Co., Easton, Pa. pp. 1586-1588 (1978).
Bechard Simon R.
Katdare Ashok V.
Kramer Kenneth A.
Cintins Marianne M.
Criares T. J.
Giesser Joanne M.
Matukaitis Paul D.
Merck & Co. , Inc.
LandOfFree
Dry mix formulation for bisphosphonic acids with lactose does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dry mix formulation for bisphosphonic acids with lactose, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dry mix formulation for bisphosphonic acids with lactose will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-135502